Kits and results of HLA antibody tests (2021, 2022)
| Program/manufacturers/kits | 2021 | 2022 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1st | 2nd | 1st | 2nd | ||||||||||||||||||||
| IHA-21-01 | IHA-21-02 | IHA-21-03 | IHA-21-04 | IHA-22-01 | IHA-22-02 | IHA-22-03 | IHA-22-04 | ||||||||||||||||
| Present | Absent | Present | Absent | Present | Absent | Present | Absent | Present | Absent | Present | Absent | Present | Absent | Present | Absent | ||||||||
| Class I screening | 1 | 21 | 22 | 22 | 22 | 21 | 21 | 22 | 22 | ||||||||||||||
| Gen-Probe/Lifecodes LifeScreen Deluxe | |||||||||||||||||||||||
| One Lambda/LABScreen Mixed | 1 | 21 | 22 | 22 | 22 | 21 | 21 | 22 | 22 | ||||||||||||||
| Class II screening | 22 | 22 | 22 | 22 | 21 | 21 | 22 | 22 | |||||||||||||||
| Gen-Probe/Lifecodes LifeScreen Deluxe | |||||||||||||||||||||||
| One Lambda/LABScreen Mixed | 22 | 22 | 22 | 22 | 21 | 21 | 22 | 22 | |||||||||||||||
| Class I phenotyping | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | |||||||||||||||
| Gen-Probe/Lifecodes Class I ID | |||||||||||||||||||||||
| One Lambda/LABScreen PRA Class I | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | |||||||||||||||
| Class II phenotyping | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | |||||||||||||||
| Gen-Probe/Lifecodes Class II ID | |||||||||||||||||||||||
| One Lambda/LABScreen PRA Class II | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | |||||||||||||||
| Class I single antigen | 18 | 6 | 24 | 24 | 24 | 24 | 24 | 25 | 25 | ||||||||||||||
| Gen-Probe/Lifecodes LSA Class I | |||||||||||||||||||||||
| One Lambda/LABScreen Single Antigen Class I | 18 | 6 | 24 | 24 | 24 | 24 | 24 | 25 | 25 | ||||||||||||||
| Class II single antigen | 24 | 24 | 24 | 24 | 24 | 24 | 25 | 25 | |||||||||||||||
| Gen-Probe/Lifecodes LSA Class II | |||||||||||||||||||||||
| One Lambda/LABScreen Single Antigen Class II | 24 | 24 | 24 | 24 | 24 | 24 | 25 | 25 | |||||||||||||||
Bold letter indicates the results which are not compliant with the intended responses. The instruments were from the following companies: Gen-Probe (San Diego, CA, USA) and One Lambda (Canoga Park, CA, USA).
Abbreviation: HLA, human leukocyte antigen.